9 METERS BIOPHARMA, INC. - FORM 10-K - EX-32.2 - EXHIBIT 32.2 - March 13, 2018

Attached files

file filename
EX-10.18 - EXHIBIT 10.18 - 9 METERS BIOPHARMA, INC.tv487458_ex10-18.htm
EX-32.1 - EXHIBIT 32.1 - 9 METERS BIOPHARMA, INC.tv487458_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - 9 METERS BIOPHARMA, INC.tv487458_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - 9 METERS BIOPHARMA, INC.tv487458_ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - 9 METERS BIOPHARMA, INC.tv487458_ex23-1.htm
EX-21.1 - EXHIBIT 21.1 - 9 METERS BIOPHARMA, INC.tv487458_ex21-1.htm
EX-10.27 - EXHIBIT 10.27 - 9 METERS BIOPHARMA, INC.tv487458_ex10-27.htm
EX-10.26 - EXHIBIT 10.26 - 9 METERS BIOPHARMA, INC.tv487458_ex10-26.htm
EX-10.25 - EXHIBIT 10.25 - 9 METERS BIOPHARMA, INC.tv487458_ex10-25.htm
EX-10.24 - EXHIBIT 10.24 - 9 METERS BIOPHARMA, INC.tv487458_ex10-24.htm
EX-10.23 - EXHIBIT 10.23 - 9 METERS BIOPHARMA, INC.tv487458_ex10-23.htm
EX-10.22 - EXHIBIT 10.22 - 9 METERS BIOPHARMA, INC.tv487458_ex10-22.htm
EX-10.21 - EXHIBIT 10.21 - 9 METERS BIOPHARMA, INC.tv487458_ex10-21.htm
EX-10.20 - EXHIBIT 10.20 - 9 METERS BIOPHARMA, INC.tv487458_ex10-20.htm
EX-10.17 - EXHIBIT 10.17 - 9 METERS BIOPHARMA, INC.tv487458_ex10-17.htm
EX-10.14 - EXHIBIT 10.14 - 9 METERS BIOPHARMA, INC.tv487458_ex10-14.htm
EX-10.13 - EXHIBIT 10.13 - 9 METERS BIOPHARMA, INC.tv487458_ex10-13.htm
EX-10.12 - EXHIBIT 10.12 - 9 METERS BIOPHARMA, INC.tv487458_ex10-12.htm
EX-10.11 - EXHIBIT 10.11 - 9 METERS BIOPHARMA, INC.tv487458_ex10-11.htm
EX-10.4 - EXHIBIT 10.4 - 9 METERS BIOPHARMA, INC.tv487458_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - 9 METERS BIOPHARMA, INC.tv487458_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - 9 METERS BIOPHARMA, INC.tv487458_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - 9 METERS BIOPHARMA, INC.tv487458_ex10-1.htm
EX-4.1 - EXHIBIT 4.1 - 9 METERS BIOPHARMA, INC.tv487458_ex4-1.htm
EX-3.1 - EXHIBIT 3.1 - 9 METERS BIOPHARMA, INC.tv487458_ex3-1.htm
10-K - 10-K - 9 METERS BIOPHARMA, INC.tv487458_10k.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jay Madan, President, Chief Business Officer and Interim Principal Financial Officer of Innovate Biopharmaceuticals, Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1)the Annual Report on Form 10-K of the Company for the year ended December 31, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

 

Date: March 13, 2018  
   
  /s/ Jay Madan
  Jay Madan
  President, Chief Business Officer and Interim Principal Financial Officer
  (Principal Financial Officer)

 

This certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

 

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

   

 

9 METERS BIOPHARMA, INC. Reports